ProfileGDS4132 / 221514_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 74% 65% 50% 45% 73% 64% 63% 67% 38% 50% 31% 29% 30% 37% 47% 35% 46% 36% 33% 36% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101226.87674
GSM201543Muscle PCOS pioglitazone 121177.90565
GSM201544Muscle PCOS pioglitazone 161136.15350
GSM201545Muscle PCOS pioglitazone 201126.60345
GSM201829Muscle PCOS pioglitazone 231234.70773
GSM201830Muscle PCOS pioglitazon 251190.93764
GSM201831Muscle PCOS pioglitazone 271185.80763
GSM201832Muscle PCOS pioglitazone 31189.83967
GSM201833Muscle PCOS pioglitazone 4190.647638
GSM201834Muscle PCOS pioglitazone 81132.33650
GSM201835Muscle PCOS after pioglitazone 10262.14231
GSM201836Muscle PCOS after pioglitazone 12259.803829
GSM201837Muscle PCOS after pioglitazone 16261.437730
GSM201838Muscle PCOS after pioglitazone 20285.8937
GSM201839Muscle PCOS after pioglitazone 232115.2147
GSM201840Muscle PCOS after pioglitazone 25284.102135
GSM201841Muscle PCOS after pioglitazone 272105.49446
GSM201842Muscle PCOS after pioglitazone 3274.53736
GSM201843Muscle PCOS after pioglitazone 4281.480733
GSM201844Muscle PCOS after pioglitazone 8285.05236